- 期刊
- OpenAccess
乳癌病患接受強度調控放射治療與護理照護介入之皮膚反應分析
NURSING INSTRUCTION TO REDUCING SKIN TOXICITY FOR BREAST CANCER PATIENTS WHO UNDERGO INTENSITY-MODULATED RADIOTHERAPY
摘要
背景：使用「強度調控放射治療」可以減輕放射治療所帶來的「皮膚副作用」，若能搭配完整衛教，增加自我照護強度，更可減輕副作用。目的：探討「乳癌」病人接受強度調控放射治療過程，給予多階段自我照護衛教之相關成效。材料及方法：本研究包含65位接受「強度調控放射治療」乳癌患者。回顧分析病人相關資料，患者皆接受多階段護理衛教。以CTCAE及RTOG分級並記錄其急性皮膚副作用，進而統計分析影響皮膚副作用之因素。結果：收集自2014年2月至2016年3月共65位病人。完成4次護理衛教與評值。急性副作用方面，RTOG分級0級1位（1.5％）；第1級54位（83.1％）；第二級10位（15.4％）。CTCAE Grade1：55位（84.6％），Grade2：10位（15.4％）。不論是RTOG或是CTCAE，都沒有病人超過第三級以上的皮膚急性副作用。結論：本研究發現大多數病患（85％）都只有發生0－1級的皮膚急性副作用。多階段給予病人自我照護護理衛教，及適時評值可整體減輕乳癌患者放射治療過程中的急性皮膚副作用。
並列摘要
The use of intensity-modulated radiation therapy reduces the skin side effects due to radiation therapy. When combined with a complete health education, the intensity of self-care is increased and side effects are decreased. Purpose: This study determines the effect of multi-stage self-care health education for patients with breast cancer who are subject to intensity-modulated radiation therapy. 65 patients with breast cancer who receive radiotherapy were enrolled. The data for the patients who received multi-stage nursing health education was used to grade and record acute skin side effects in patients using CTCAE and RTOG and for a statistical analysis of the factors affecting skin side effects. Data from a total of 65 patients from February 2014 to March 2016 was collected. The patients completed 4 nursing health education and assessments. In terms of acute side effects, 1 patient (1.5%) suffered from RTOG grade 0, 54 patients (83.1%) suffered from RTOG grade 1 and 10 patients (15.4%) suffered from RTOG grade 2. 55 patients (84.6%) suffered from CTCAE Grade 1 and 10 patients (15.4%) suffered from CTCAE Grade 2. No patients suffered from Grade 3 RTOG or CTCAE. This study determines that most patients (85%) experience Grade 0-1 acute skin side effects. Multi-stage self-care nursing health education for patients and timely assessments reduce the overall incidence of acute skin side effects in patients with breast cancer during radiotherapy.
延伸閱讀
- Chao, C. W., Woo, P., Hsiung, C. Y., Ma, H. K., Lin, J. P., & Lai, Y. C. (2011). 乳癌強度調控放射治療計畫之最適化研究. 台灣應用輻射與同位素雜誌, 7(2), 83-93. https://doi.org/10.29832/TJARI.201106.0005
- 趙家緯、馬漢光、李桂樑、林招膨、簡宏伊（2011）。乳癌強度調控放射治療與傳統相切照野治療技術治療計畫之最適化比較。台灣應用輻射與同位素雜誌，7(1)，41-48。https://doi.org/10.29832/TJARI.201103.0006
- 周佩君（2006）。乳癌病人放射治療期間的照射劑量、症狀困擾與細胞激素之相關性探討〔碩士論文，臺北醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0007-1704200715031712
- 劉煥彰、黃意婷、陳臣苑、陳柏元、劉義誠（2019）。回溯研究乳癌放射治療時的擺位誤差與皮膚反應。中華放射線技術學雜誌，43(1)，20-26。https://www.airitilibrary.com/Article/Detail?DocID=16849418-201903-201907220004-201907220004-20-26
- 張滋娉、李月麗、馬秀玲（2019）。Nursing Care Experience of a Newly-diagnosed Breast Cancer Patient on Neoadjuvant Chemotherapy and Target Therapy。腫瘤護理雜誌，19()，123-135。https://doi.org/10.6880/TJON.201903/SP_19.11